Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: A single-center experience

Clinical Transplantation

Volumn 28, Issue 6, 2014, Pages 656-661

  Shiratori, Souichi ^a   Wakasa, Kentaro ^b   Okada, Kohei ^a   Sugita, Junichi ^a   Akizawa, Koji ^c   Shigematsu, Akio ^a,c   Hashimoto, Daigo ^a   Fujimoto, Katsuya ^a   Endo, Tomoyuki ^a   Kondo, Takeshi ^a   Shimizu, Chikara ^c   Hashino, Satoshi ^a   Teshima, Takanori ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Obihiro Kosei General Hospital   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Bacterial infection; Central venous catheter; Neutropenia; Stenotrophomonas maltophilia

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; LEVOFLOXACIN; MINOCYCLINE;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BLOODSTREAM INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHRONIC MYELOID LEUKEMIA; ENGRAFTMENT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; STENOTROPHOMONAS MALTOPHILIA INFECTION; ALLOTRANSPLANTATION; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; FOLLOW UP; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84901926928     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12356     Document Type: Article

References (29)

1. Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009: 9: 312.
2. Cervia JS, Ortolano GA, Canonica FP. Hospital tap water as a source of Stenotrophomonas maltophilia infection. Clin Infect Dis 2008: 46: 1485.
3. Hoefel D, Monis PT, Grooby WL, Andrews S, Saint CP. Profiling bacterial survival through a water treatment process and subsequent distribution system. J Appl Microbiol 2005: 99: 175.
4. Labarca JA, Leber AL, Kern VL et al. Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 2000: 30: 195.
5. Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007: 26: 229.
6. Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 2008: 70: 101.
7. Tunger O, Vural S, Cetin CB, Keles G, Borand H, Gazi H. Clinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia bacteremia episodes in a Turkish intensive care unit. J Chemother 2007: 19: 658.
8. Araoka H, Baba M, Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis 2010: 29: 605.
9. Nseir S, Di Pompeo C, Brisson H et al. Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care 2006: 10: R143.
10. Lai CH, Wong WW, Chin C et al. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect 2006: 12: 986.
11. Metan G, Hayran M, Hascelik G, Uzun O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 2006: 38: 527.
12. Boktour M, Hanna H, Ansari S et al. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 2006: 106: 1967.
13. Trouillet JL, Chastre J, Vuagnat A et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998: 157: 531.
14. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis 2007: 26: 13.
15. Samonis G, Karageorgopoulos DE, Maraki S et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 2012: 7: e37375.
16. Apisarnthanarak A, Mayfield JL, Garison T et al. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 2003: 24: 269.
17. Demiraslan H, Sevim M, Pala Ç et al. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol 2013: 97: 414.
18. Takahashi N, Yoshioka T, Kameoka Y et al. Fatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma. J Infect Chemother 2011: 17: 858.
19. Chaplow R, Palmer B, Heyderman R, Moppett J, Marks DI. Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome. Bone Marrow Transplant 2010: 45: 1109.
20. Tsai SH, Chao TY, Chou TD, Dai MS. Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient. Ann Hematol 2003: 82: 452.
21. Micozzi A, Venditti M, Monaco M et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000: 31: 705.
22. Sefcick A, Tait RC, Wood B. Stenotrophomonas maltophilia: an increasing problem in patients with acute leukaemia. Leuk Lymphoma 1999: 35: 207.
23. Tada K, Kurosawa S, Hiramoto N et al. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant 2013: 48: 74.
24. Araoka H, Fujii T, Izutsu K et al. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis 2012: 14: 355.
25. Yeshurun M, Gafter-Gvili A, Thaler M, Keller N, Nagler A, Shimoni A. Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience. Infection 2010: 38: 211.
26. Narimatsu H, Matsumura T, Kami M et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005: 11: 429.
27. Kagen J, Zaoutis TE, McGowan KL, Luan X, Shah SS. Bloodstream infection caused by Stenotrophomonas maltophilia in children. Pediatr Infect Dis J 2007: 26: 508.
28. Waters VJ, Gómez MI, Soong G, Amin S, Ernst RK, Prince A. Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect Immun 2007: 75: 1698.
29. de Oliveira-Garcia D, Dall'Agnol M, Rosales M et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 2003: 5: 625.